// company-profile

Zentalis Pharmaceuticals, Inc.

ZNTL
ExchangeNasdaqSectorPharmaceutical PreparationsFilings66Insiders23
// api This Zentalis Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Walker Luke Nathaniel.

// 90-day insight

Over the last 90 days, Zentalis Pharmaceuticals, Inc. insiders bought $0 across 6 transactions with no open-market sales.

  • Most active insider: Walker Luke Nathaniel with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Zentalis Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$92.7M
QoQ change
+94.1%
Reporting period
2026-03-31
#1
5AM Venture Management, LLC
CIK 1799883
$9.2M
3.9M shares
#2
Squadron Capital Management LLC
CIK 2050709
$8.5M
3.6M shares
#3
TWO SIGMA INVESTMENTS, LP
CIK 1179392
$6.9M
3.0M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Walker Luke NathanielZNTL
Award
57,100$0.00$0K
Jun 16, 2026Skvarka JanZNTL
Award
57,100$0.00$0K
Jun 16, 2026Kariuki EnochZNTL
Award
57,100$0.00$0K
Jun 16, 2026Myers Scott DunsethZNTL
Award
57,100$0.00$0K
Jun 16, 2026Johnson David MichaelZNTL
Award
57,100$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.